U.s. Advisers Back Experimental Obesity Pill

SILVER SPRING, Maryland (Reuters) - Experimental obesity drug Qnexa won the backing of U.S. health advisors on Wednesday, raising hopes for approval of the first prescription weight-loss pill in 13 years.

BING NEWS:
  • AstraZeneca says experimental obesity pill safe in early-stage trial
    AstraZeneca said on Monday its experimental weight-loss pill, licensed a year ago from China's Eccogene for up to $2 billion, was safe and tolerable in an early-stage trial, with side effects ...
    11/4/2024 - 4:27 am | View Link
  • AstraZeneca says experimental obesity pill safe and tolerable in early-stage trial
    AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an early-stage trial, with side effects consistent with the GLP-1 drug class.
    11/4/2024 - 2:04 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News